Showing results (741-750 of 794) with videos related to

Sort By:
Pageof 80
European Urology|April 15, 2000
The prognostic significance of S-phase analysis in stage Ta/T1 bladder cancer. A Southwest Oncology Group StudyR W deVere White, A D Deitch, S Daneshmand, et al.
The Journal of Clinical Endocrinology and Metabolism|August 11, 2021
Metastatic Medullary Thyroid Cancer: The Role of 68Gallium-DOTA-Somatostatin Analogue PET/CT and Peptide Receptor Radionuclide TherapyAimee R Hayes, Alexander Crawford, Khulood Al Riyami, et al.
Pituitary|September 29, 2016
Long-term outcomes of children treated for Cushing's disease: a single center experienceGalina Yordanova, Lee Martin, Farhad Afshar, et al.
Endocrine-Related Cancer|January 9, 2023
Diagnosis and management of parathyroid carcinoma: a state-of-the-art reviewPia Roser, Bianca M Leca, Claudia Coelho, et al.
Journal of Endocrinological Investigation|August 24, 2022
Sellar and parasellar lesions in the transition age: a retrospective Italian multi-centre studyT Feola, R Sa Pirchio, G Puliani, et al.
Cancers|November 14, 2023
PD-L1 and HIF-2α Upregulation in Head and Neck Paragangliomas after EmbolizationAlessa Fischer, Umberto Maccio, Katharina Wang, et al.
European Journal of Endocrinology|July 27, 2006
Somatostatin analogues stimulate p27 expression and inhibit the MAP kinase pathway in pituitary tumoursErika Hubina, Alexandra M Nanzer, Matthew R Hanson, et al.
Human Molecular Genetics|November 17, 2018
Association of prolactin receptor (PRLR) variants with prolactinomasCaroline M Gorvin, Paul J Newey, Angela Rogers, et al.
Pageof 80